Terms: = Breast cancer AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS
63 results:
1. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T; Iwamoto T; Niikura N; Watanabe K; Kikawa Y; Kobayashi K; Iwakuma N; Okamura T; Tada H; Ozaki S; Okuno T; Toh U; Yamamoto Y; Tsuneizumi M; Ishiguro H; Masuda N; Saji S
ESMO Open; 2024 Apr; 9(4):102385. PubMed ID: 38387111
[TBL] [Abstract] [Full Text] [Related]
2. SIRT6 promotes metastasis and relapse in HER2-positive breast cancer.
Andreani C; Bartolacci C; Persico G; Casciaro F; Amatori S; Fanelli M; Giorgio M; Galié M; Tomassoni D; Wang J; Zhang X; Bick G; Coppari R; Marchini C; Amici A
Sci Rep; 2023 Dec; 13(1):22000. PubMed ID: 38081972
[TBL] [Abstract] [Full Text] [Related]
3. Association of Germline Variation in Driver Genes with breast cancer Risk in Chilean Population.
Morales-Pison S; Tapia JC; Morales-González S; Maldonado E; Acuña M; Calaf GM; Jara L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003265
[TBL] [Abstract] [Full Text] [Related]
4. Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel.
Yan K; Niu L; Wu B; He C; Deng L; Chen C; Lan Z; Lin C; Kuang W; Lin H; Zou J; Zhang W; Luo Z
Ann Med; 2023; 55(2):2280708. PubMed ID: 37967237
[TBL] [Abstract] [Full Text] [Related]
5. Population-specific Mutation Patterns in breast Tumors from African American, European American, and Kenyan Patients.
Tang W; Zhang F; Byun JS; Dorsey TH; Yfantis HG; Ajao A; Liu H; Pichardo MS; Pichardo CM; Harris AR; Yang XR; Figueroa JD; Sayed S; Makokha FW; Ambs S
Cancer Res Commun; 2023 Nov; 3(11):2244-2255. PubMed ID: 37902422
[TBL] [Abstract] [Full Text] [Related]
6. Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population.
Morales-Pison S; Gonzalez-Hormazabal P; Tapia JC; Salas-Burgos A; Ampuero S; Gómez F; Waugh E; Reyes JM; Jara L
Biol Res; 2022 May; 55(1):20. PubMed ID: 35637532
[TBL] [Abstract] [Full Text] [Related]
7. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract] [Full Text] [Related]
8. An integrated computational approach to screening of alkaloids inhibitors of tbx3 in breast cancer cell lines.
Paul A; Limon MBH; Hossain MM; Raza MT
J Biomol Struct Dyn; 2023 Apr; 41(7):3025-3041. PubMed ID: 35253621
[TBL] [Abstract] [Full Text] [Related]
9. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
10. Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.
Wijetunga NA; Dos Anjos CH; Zhi WI; Robson M; Tsai CJ; Yamada Y; Dover L; Gillespie EF; Xu AJ; Yang JT
Cancer Med; 2021 Aug; 10(15):5163-5174. PubMed ID: 34159748
[TBL] [Abstract] [Full Text] [Related]
11. Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
King MC; Sardi A; Velez-Mejia C; Sittig M; Ledakis P
Urology; 2021 Sep; 155():210-213. PubMed ID: 34048828
[TBL] [Abstract] [Full Text] [Related]
12. A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cells.
Bhat-Nakshatri P; Gao H; Sheng L; McGuire PC; Xuei X; Wan J; Liu Y; Althouse SK; Colter A; Sandusky G; Storniolo AM; Nakshatri H
Cell Rep Med; 2021 Mar; 2(3):100219. PubMed ID: 33763657
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular breast cancer.
Richard F; Majjaj S; Venet D; Rothé F; Pingitore J; Boeckx B; Marchio C; Clatot F; Bertucci F; Mariani O; Galant C; Eynden GVD; Salgado R; Biganzoli E; Lambrechts D; Vincent-Salomon A; Pruneri G; Larsimont D; Sotiriou C; Desmedt C
Clin Cancer Res; 2020 Dec; 26(23):6254-6265. PubMed ID: 32943456
[TBL] [Abstract] [Full Text] [Related]
14. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of tbx3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract] [Full Text] [Related]
15. Isoform-specific promotion of breast cancer tumorigenicity by tbx3 involves induction of angiogenesis.
Krstic M; Hassan HM; Kolendowski B; Hague MN; Anborgh PH; Postenka CO; Torchia J; Chambers AF; Tuck AB
Lab Invest; 2020 Mar; 100(3):400-413. PubMed ID: 31570773
[TBL] [Abstract] [Full Text] [Related]
16. Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular breast cancer and Normal PAM50 Subtype.
Lehrer S; Green S; Dembitzer FR; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2019; 16(3):147-153. PubMed ID: 31018945
[TBL] [Abstract] [Full Text] [Related]
17. tbx3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
[TBL] [Abstract] [Full Text] [Related]
18. The special stemness functions of tbx3 in stem cells and cancer development.
Dong L; Lyu X; Faleti OD; He ML
Semin Cancer Biol; 2019 Aug; 57():105-110. PubMed ID: 30268432
[TBL] [Abstract] [Full Text] [Related]
19. The Genomic Landscape of Endocrine-Resistant Advanced breast cancers.
Razavi P; Chang MT; Xu G; Bandlamudi C; Ross DS; Vasan N; Cai Y; Bielski CM; Donoghue MTA; Jonsson P; Penson A; Shen R; Pareja F; Kundra R; Middha S; Cheng ML; Zehir A; Kandoth C; Patel R; Huberman K; Smyth LM; Jhaveri K; Modi S; Traina TA; Dang C; Zhang W; Weigelt B; Li BT; Ladanyi M; Hyman DM; Schultz N; Robson ME; Hudis C; Brogi E; Viale A; Norton L; Dickler MN; Berger MF; Iacobuzio-Donahue CA; Chandarlapaty S; Scaltriti M; Reis-Filho JS; Solit DB; Taylor BS; Baselga J
Cancer Cell; 2018 Sep; 34(3):427-438.e6. PubMed ID: 30205045
[TBL] [Abstract] [Full Text] [Related]
20. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
[TBL] [Abstract] [Full Text] [Related]
[Next]
